Luspatercept is emerging as a frontline option for lower-risk MDS patients, offering sustained transfusion independence with ...
Myelodysplastic syndrome (MDS) is independently associated with incident cardiovascular disease (CVD), according to a study published online Nov. 10 in the Canadian Journal of Cardiology. Hiroyuki ...
Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of Clinical Immunology.
Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.
Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients Purpose: To assess the incidence and ...
A study identifies TET2–GFI1 axis as a critical brake suppressing malignant transformation of hematopoietic stem cells in myelodysplastic syndromes Published on April 01, 2026, in Volume 2, article ...
Early low-dose lenalidomide significantly reduces mutational burden without increasing AML risk in non-transfusion-dependent del(5q) MDS.
Tobacco smoking is linked to specific genetic mutations in MDS, affecting chromatin modification and RNA splicing pathways. A dose-response relationship exists, with higher smoking intensity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results